1. Home
  2. CRTO vs PSNL Comparison

CRTO vs PSNL Comparison

Compare CRTO & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$16.41

Market Cap

780.6M

ML Signal

HOLD

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$5.99

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
PSNL
Founded
2005
2011
Country
France
United States
Employees
3649
N/A
Industry
Advertising
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.6M
729.1M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
CRTO
PSNL
Price
$16.41
$5.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$34.00
$12.20
AVG Volume (30 Days)
235.3K
1.9M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
38.95
33.58
EPS
0.15
N/A
Revenue
$2,296,692,000.00
$69,648,000.00
Revenue This Year
N/A
$15.34
Revenue Next Year
$5.54
$41.46
P/E Ratio
$5.92
N/A
Revenue Growth
27.65
N/A
52 Week Low
$15.58
$3.84
52 Week High
$28.91
$11.50

Technical Indicators

Market Signals
Indicator
CRTO
PSNL
Relative Strength Index (RSI) 37.25 46.27
Support Level N/A $5.81
Resistance Level $20.10 $6.99
Average True Range (ATR) 0.90 0.46
MACD -0.31 0.06
Stochastic Oscillator 18.63 60.38

Price Performance

Historical Comparison
CRTO
PSNL

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: